DPP4/CD26 is a single-pass transmembrane protein with multiple functions on glycemic
control, cell migration and proliferation, and the immune system, among others. It has …

Background and aims Treatment of type 2 diabetes (T2D) in patients with compensated
cirrhosis is challenging due to hypoglycemic risk, altered pharmacokinetics, and the lack of …

Liver fibrosis is caused by chronic liver injury. There are limited treatments for it, and the
pathogenesis is unclear. Therefore, there is an urgent need to explore the pathogenesis of …

Introduction Metabolic-associated fatty liver disease (MAFLD) previously known but still
debatable, as nonalcoholic fatty liver disease (NAFLD) is one of the main causes of chronic …

Liver fibrosis is a pathological condition characterized by replacement of normal liver tissue
with scar tissue, and also the leading cause of liver-related death worldwide. During the …

Leptin inhibits food intake and reduces the size of body fat depots, changing adipocyte
sensitivity to insulin to restrain lipid accrual. This adipokine may modulate the production of …

Abstract Ethnopharmacological relevance Huang-Qi-Ge-Gen decoction (HGD) is a
traditional Chinese medicine prescription that has been used for centuries to treat …

Non-alcoholic fatty liver disease (NAFLD), marked by inflammation, oxidative stress, and
insulin resistance (IR), often has a significant impact on public health. To date, Sangyod rice …

Introduction Experimental hepatopulmonary syndrome (HPS) is best reproduced in the rat
common bile duct ligation (CBDL) model. Vildagliptin (Vild) is an anti-hyperglycemic drug …

Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) is caused by
various factors, including genetic and/or environmental factors, and has complicated …